Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Change in Intangibles (2018 - 2025)

Ultragenyx Pharmaceutical has reported Change in Intangibles over the past 6 years, most recently at $15.0 million for Q1 2025.

  • Quarterly Change in Intangibles rose 50.0% to $15.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, up 15.38% year-over-year, with the annual reading at $15.0 million for FY2025, 15.38% up from the prior year.
  • Change in Intangibles was $15.0 million for Q1 2025 at Ultragenyx Pharmaceutical, up from $500000.0 in the prior quarter.
  • Over five years, Change in Intangibles peaked at $30.0 million in Q1 2022 and troughed at $500000.0 in Q4 2023.
  • The 4-year median for Change in Intangibles is $2.5 million (2023), against an average of $8.7 million.
  • Year-over-year, Change in Intangibles changed 0.0% in 2024 and then soared 50.0% in 2025.
  • A 4-year view of Change in Intangibles shows it stood at $30.0 million in 2022, then plummeted by 98.33% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then surged by 2900.0% to $15.0 million in 2025.
  • Per Business Quant, the three most recent readings for RARE's Change in Intangibles are $15.0 million (Q1 2025), $500000.0 (Q4 2024), and $2.5 million (Q2 2024).